Neovascular Glaucoma

Neovascular Glaucoma, also known as glaucoma, neovascular, is related to central retinal vein occlusion and retinal vein occlusion, and has symptoms including progressive peripheral vision loss An important gene associated with Neovascular Glaucoma is TGFB2 (Transforming Growth Factor Beta 2), and among its related pathways/superpathways are Apoptotic Pathways in Synovial Fibroblasts and ERK Signaling. The drugs Bevacizumab and Mitomycins have been mentioned in the context of this disorder. Affiliated tissues include eye and endothelial, and related phenotypes are glaucoma and visual loss